Genomic profiling may reveal new drug targets in urothelial carcinoma

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer

Management after radical prostatectomy: early adjuvant radiotherapy or wait-and-see?

Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?

When and whether to conduct endocrine therapy in non-metastatic prostate cancer

High BMI beneficial in kidney cancer

Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer

New approach to prostate cancer screening

Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer

Combination of pazopanib and paclitaxel safe in urothelial cancer

Tackling renal cancer with a combination of autologous immunotherapy and sunitinib

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer